News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Compugen (CGEN) Adds Two Potential Therapeutic Proteins To Its Research Pipeline



10/19/2005 5:11:38 PM

Speaking today at the BIO 2004 Annual International Convention, Martin Gerstel, Chairman of Compugen Ltd. (Nasdaq:CGEN), disclosed two novel potential therapeutic proteins which Compugen has recently added to its research pipeline: CGEN M-3, a soluble kinase receptor with potential applications in various types of cancer, and CGEN P-4, a peptide with potential applications in obesity and various eating disorders.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES